Evidence map›Paper›PMID 25020061›Full record

Trial reportPloS one2014

Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signaling.

Mikkel Holm Vendelbo, Andreas Buch Møller, Britt Christensen, Birgitte Nellemann, Berthil Frederik Forrest Clasen, K Sreekumaran Nair, Jens Otto Lunde Jørgensen, Niels Jessen, Niels Møller

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Anti-Atrophic Effects of Dichotomine B fromMolecules (Basel, Switzerland) · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Mechanisms driving fasting-induced protection from genotoxic injury in the small intestine.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Article
  14. Article
  15. Article
  16. Dietary restriction in senolysis and prevention and treatment of disease.Critical reviews in food science and nutrition · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Mikkel Holm VendelboDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Andreas Buch MøllerResearch Laboratory for Biochemical Pathology, Aarhus University Hospital, Aarhus, Denmark.
Britt ChristensenDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Birgitte NellemannDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Berthil Frederik Forrest ClasenDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark; Research Laboratory for Biochemical Pathology, Aarhus University Hospital, Aarhus, Denmark.
K Sreekumaran NairDivision of Endocrinology, Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota, United States of America.
Jens Otto Lunde JørgensenDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Niels JessenDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark; Research Laboratory for Biochemical Pathology, Aarhus University Hospital, Aarhus, Denmark; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Niels MøllerDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Aarhus University Hospital · DKMayo Clinic in Florida · US

Funding

TECHNOLOGY NMR SPECTROSCOPYU24DK100469 · NIDDK · MAYO CLINIC ROCHESTER · PI NAIR, K SREEKUMARAN · 2013 to 2017
$9.0M
NIDDK NIH HHS U24 DK100469
6 · The paper itself

Abstract

aimFasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth.

methodsEight healthy male volunteers were studied twice: in the postabsorptive state and following 72 hours of fasting. Regional muscle amino acid kinetics was measured in the forearm using amino acid tracers. Signaling to protein synthesis and breakdown were assessed in skeletal muscle biopsies obtained during non-insulin and insulin stimulated conditions on both examination days.

resultsFasting significantly increased forearm net phenylalanine release and tended to decrease phenylalanine rate of disappearance. mTOR phosphorylation was decreased by ∼50% following fasting, together with reduced downstream phosphorylation of 4EBP1, ULK1 and rpS6. In addition, the insulin stimulated increase in mTOR and rpS6 phosphorylation was significantly reduced after fasting indicating insulin resistance in this part of the signaling pathway. Autophagy initiation is in part regulated by mTOR through ULK1 and fasting increased expression of the autophagic marker LC3B-II by ∼30%. p62 is degraded during autophagy but was increased by ∼10% during fasting making interpretation of autophagic flux problematic. MAFbx and MURF1 ubiquitin ligases remained unaltered after fasting indicating no change in protesomal protein degradation.

conclusionsOur results show that during fasting increased net phenylalanine release in skeletal muscle is associated to reduced mTOR activation and concomitant decreased downstream signaling to cell growth.

Indexed as

Amino AcidsAnalysis of VarianceBlotting, WesternCross-Over StudiesEnergy MetabolismFastingFatty Acids, NonesterifiedGas Chromatography-Mass SpectrometryGlucagonHumansMaleMuscle, SkeletalPhenylalanineRadioimmunoassaySignal TransductionTOR Serine-Threonine KinasesAmino AcidsFatty Acids, NonesterifiedGlucagonMTOR protein, humanPhenylalanineTOR Serine-Threonine KinasesTyrosine

Identifiers

PMID25020061
PMCPMC4096723
OpenAlexW2014425292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.